spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 6


Fig. 6. Pak permits activation of NF-{kappa}B to mediate resistance to apoptosis in mammary acini. (A) Bar graph indicating how inhibiting activation of NF-{kappa}B by treating mammary acini with SN50 peptide permits Trail-induced apoptosis. MECs were grown in rBM for ten days and treated with SN50 or inactive, scrambled SN50M peptide. Polarized acini were treated with Trail (1 µg/ml) and after 24 hours the acini were stained and quantified for activated caspase 3. (B) Bar graph illustrating how ectopically expressed wild-type Pak1 can restore resistance to apoptosis to N17Rac-expressing mammary acini treated with Trail (N17Rac), but the acini remain death sensitive if NF-{kappa}B activation is prevented by pre-incubation with SN50. 3D mammary acini were infected with adenovirus, pre-incubated for 24 hours with either SN50 to inhibit NF-{kappa}B activation or its non-active analogue SN50M, and treated with Trail (1 µg/ml) for 24 hours. The percentage apoptosis for (A) and (B) was calculated by scoring the number of activated caspase-3-positive cells divided by the total cell number. (C) Confocal immunofluorescence microscopy images showing NF-{kappa}B p65 nuclear translocation in response to treatment with Trail (90 min) in 3D mammary acini expressing either vector (control), the Pak activity inhibitor (PID), N17Rac (N17Rac) or N17Rac and wild-type Pak1 (N17Rac/Pak1 WT). Note the presence of high nuclear levels of p65, as indicated by "n" and identified by arrow, in response to Trail stimulation in control and N17Rac/Pak1-WT-expressing mammary tissues and decreased levels in acini with reduced Rac or Pak activity. Bar, 10 µm. n, nucleus. (D) Quantification of nuclear p65 in 50-100 representative images as shown in C. (E) Bar graph showing how expression of a wild-type p65 transgene restores Trail-induced death-resistance to apoptosis-sensitized N17Rac- and PID-expressing mammary acini. (F) Bar graph showing how inhibiting activation of NF-{kappa}B through expression of the I{kappa}B{alpha}M super-repressor permits Trail-dependent induction of death in 3D mammary acini despite elevated levels of Pak1. Results are the mean ± s.e.m. of three separate experiments. *P<=0.05; **P<=0.01; ***P<=0.001.





Right arrow Return to article